
SOC Telemed (TLMD) Earnings Dates & Reports
SOC Telemed (TLMD) Most Recent Earnings
Report Date
Period EndingQ4 2021
Est. EPS-$0.15
Actual EPS-$0.13
EarningsBeat
SOC Telemed (TLMD) Earnings
View the latest SOC Telemed (TLMD) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in SOC Telemed (TLMD)
Order type
Buy in
Order amount
Est. shares
0 shares
SOC Telemed (TLMD) Earnings per Share (EPS) History
Signup for full accessBrowse free
SOC Telemed (TLMD) Latest Earnings
The value each TLMD share was expected to gain vs. the value each share gained.
SOC Telemed (TLMD) reported its most recent earnings on for Q4 2021, posting earnings per share (EPS) of -$0.13. This exceeded analysts' expectations of -$0.15 by 13.33%, marking a Beat.
For comparison, SOC Telemed reported EPS of -$1.87 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.
SOC Telemed (TLMD) Earnings History
SOC Telemed (TLMD) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the SOC Telemed’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
SOC Telemed (TLMD) Earnings FAQs
SOC Telemed (TLMD) last reported earnings on Mar 30, 2022 for Q4 2021, posting an EPS of -$0.13, which Beat the estimate of -$0.15 by 13.33%.
For Q4 2021, SOC Telemed (TLMD) reported an EPS of -$0.13, exceeding analysts' estimate of -$0.15 by 13.33%.
For Q4 2021, SOC Telemed (TLMD) Beat expectations with an actual EPS of -$0.13 vs. an estimated EPS of -$0.15.
Following the last earnings report on Mar 30, 2022, SOC Telemed (TLMD)'s stock price moved — from — to —.
The next SOC Telemed (TLMD) earnings call is scheduled for Mar. 30, 2022, where executives will discuss financial results and outlook.